Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis-Reference-Cited by-同舟云学术

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis

Published:2019-05-30 Issue:11 Volume:33 Page:2610-2618
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Tachibana Takayoshi, ,Kanda Junya^ORCID,Ishizaki Takuma,Najima Yuho,Tanaka Masatsugu,Doki Noriko,Fujiwara Shin-ichiro,Kimura Shun-ichi,Onizuka Makoto,Takahashi Satoshi,Saito Takeshi,Mori Takehiko,Fujisawa Shin,Sakaida Emiko,Matsumoto Kenji,Aotsuka Nobuyuki,Goto Moritaka,Watanabe Reiko,Shono Katsuhiro^ORCID,Usuki Kensuke,Tsukada Nobuhiro,Kanamori Heiwa,Kanda Yoshinobu,Okamoto Shinichiro,

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0494-9.pdf

Reference40 articles.

1. Wong R, Shahjahan M, Wang X, Thall PF, De Lima M, Khouri I, et al. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transpl. 2005;11:108–14.

2. Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, et al. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Bone Marrow Transpl. 2006;37:45–50.

3. Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730–8.

4. Watanabe N, Takahashi Y, Matsumoto K, Hama A, Muramatsu H, Doisaki S, et al. Prognostic factors for outcomes of pediatric patients with refractory or relapsed acute leukemia undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transpl. 2011;17:516–23.

5. Medeot M, Tiribelli M, Patriarca F, Sperotto A, Geromin A, Fanin R. Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy. Am J Hematol. 2014;89:933–4.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models;Biomedicine & Pharmacotherapy;2024-10

2. Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis;Annals of Hematology;2024-02-23

3. Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission;Leukemia;2023-12-21

4. Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial;Frontiers in Oncology;2023-08-18

5. Chimeric antigen receptor T-cell therapy for T-ALL and AML;Frontiers in Oncology;2022-11-29